Zanubrutinib
Update Venetoclax in CLL
Acalabrutinib
(Update) Acalabrutinib in CLL and MCL
Obinutuzumab
NCCN Guidelines for Patients
Patient Power
NCCN COVID-19 Resources Page
ASH: COVID-19 Resources for Managing Blood Cancers